1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to patients with extrarenal symptoms

Guardat en:

Dades bibliogràfiques
Autors principals:	Richard Furie, Michelle Petri, Judith A James, Kenneth Kalunian, Maria Dall’Era, Jill Buyon, Chaim Putterman, Peter Izmirly, Betty Diamond, Jessica Li, Jennifer Anolik, H Michael Belmont, Philip Carlucci, Deepak Rao, Andrea Fava, Diane Kamen, Celine Berthier, Jose Monroy-Trujillo, Kristin Haag, William Apruzzese, Sean Connery, Fernanda Payan-Schober, Kerry Cho, Kristina Deonaraine, Derek Fine, Heather T Gold, Susana Serrate-Sztein
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2022-12-01
Col·lecció:	Lupus Science and Medicine
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars